New diagnostic criteria (2023) for slowly progressive type 1 diabetes (SPIDDM): Report from Committee on Type 1 Diabetes in Japan Diabetes Society (English version) Akira ShimadaEiji KawasakiHiroshi Ikegami Report of the Committee 08 January 2024 Pages: 1 - 4
Third Report of the Japan Diabetes Society (JDS)/Japanese Cancer Association (JCA) Joint Committee on diabetes and cancer: summary of the results of a questionnaire survey of oncologists and diabetologists—secondary publication Atsushi GotoKen OhashiHirotaka Watada Report of the Committee 08 January 2024 Pages: 5 - 18
Prevalence and characteristics of diabetic symmetric sensorimotor polyneuropathy in Japanese patients with type 2 diabetes: the Japan Diabetes Complication and its Prevention Prospective study (JDCP study 10) Hideki KamiyaTatsuhito HimenoJiro Nakamura Report of the Committee 12 January 2024 Pages: 19 - 27
Adipose Tissue Plasticity and Insulin Signaling in the Pathogenesis of Type 2 Diabetes Masaji Sakaguchi Review Article 18 December 2023 Pages: 28 - 33
Exploring mechanisms underlying diabetes comorbidities and strategies to prevent vascular complications Takayoshi Sasako Review Article 18 December 2023 Pages: 34 - 40
Effectiveness of management protocol for insulin balls in diabetics: a scoping review Tomomi HoriguchiSayuri NakamuraJunko Sugama Review Article 25 October 2023 Pages: 41 - 57
Impact of diabetic peripheral neuropathy on gait abnormalities in patients with type 2 diabetes mellitus Samir H. Assaad KhalilHany Mohammed Ali El DeebNoha Gaber Amin Original Article 16 August 2023 Pages: 58 - 66
Association of treatment satisfaction and physician trust with glycemic control among primary care patients with type 2 diabetes in Egypt Hazem A. Sayed AhmedNada Emad AbdelsalamNahed Amen Eldahshan Original Article 18 August 2023 Pages: 67 - 75
Safety and glycemic control with insulin degludec use in clinical practice: results from a 3-year Japanese post-marketing surveillance study Takashi MurataLise Lotte N. HusemoenMunehide Matsuhisa Original Article 18 August 2023 Pages: 76 - 85
A natural Nrf2 activator glucoraphanin improves hepatic steatosis in high-fat diet-induced obese male mice associated with AMPK activation Suratsawadee PromsuwanKazuki SawamotoYumi Takiyama Original Article 29 August 2023 Pages: 86 - 98
The efficacy of switching basal–bolus insulin therapy to basal insulin-supported oral therapy with a glinide and an α-glucosidase inhibitor in patients with type 2 diabetes depends on insulin secretory capacity, but not on blood glucose profiles and insulin dosages prior to the switching Toshihito AndoMasaki KondoHideki Kamiya Original Article 04 September 2023 Pages: 99 - 108
Association of scan frequency with CGM-derived metrics and influential factors in adults with type 1 diabetes mellitus Naoki SakaneYushi HirotaTakashi Murata Original Article 12 September 2023 Pages: 109 - 116
The Japanese version of Problem Areas in Diabetes Scale: a clinical and research tool to assess emotional functioning among people with diabetes Yasuaki HayashinoMasashi GotoHitoshi Ishii Original Article 13 September 2023 Pages: 117 - 122
The predictive role of serum uric acid levels before pregnancy in the development of gestational diabetes mellitus Azam GhaneiGolnaz MohammadzadeAli Emami Meybodi Original Article 14 September 2023 Pages: 123 - 129
Type 1 diabetes mellitus affected by potential toxicity from long-term use of nivolumab Yuma MotomuraShin UraiWataru Ogawa Case Report 28 August 2023 Pages: 130 - 134
Life-threatening coronary vasospasm in patients with type 2 diabetes with SGLT2 inhibitor-induced euglycemic ketoacidosis: a report of two consecutive cases Junko KawaharaBunji KakuYoshio Hiraiwa Case Report 13 November 2023 Pages: 135 - 140
Correction: Trends in clinical characteristics and factors associated with initial prescription of SGLT2 inhibitors in Japanese patients with type 2 diabetes mellitus Hiroshi TakahashiYuka SuganumaRimei Nishimura Correction 12 December 2023 Pages: 141 - 141
